Medpage Today on MSN1d
Semaglutide Tied to Small Risk of Potentially Blinding Eye Condition
The use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...
Medscape3d
Obinutuzumab a Success in Phase 3 Trial for Lupus Nephritis
Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...
FiercePharma18h
Genentech, Novartis join forces to raise awareness of food allergies’ impact on families
Genentech and Novartis have teamed up with Food Allergy Research & Education (FARE) to enhance the safety of children with ...
Advances in vaccine technology and the road ahead
Explore the evolution of vaccine technology from Jenner to mRNA, highlighting India's role in COVID-19 vaccine development.
FierceBiotech16h
German research institute teams up with Barbados to improve cardiometabolic treatments for Black individuals
BioMed X Institute is teaming up with the Barbados government in an effort to accelerate cardiometabolic treatments for ...
manilatimes12h
Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), ...
MedPage Today on MSN9h
Researchers Describe Rare Syndrome After COVID Vaccine
Immune cell populations of people with post-vaccination syndrome had lower levels of effector CD4 T cells and higher levels ...
Stockhead on MSN2d
Biocurious: Cashed up and pursuing the ‘c’ word, Imugene is on the verge of transforming cancer immunotherapy
Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.
F. Hoffmann-La Roche Ltd: Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, immun ...
Extensive-Stage Small Cell Lung Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
The leading Extensive-Stage Small Cell Lung Cancer Companies such as Shanghai Henlius Biotech, MacroGenics, Inc., RayzeBio, ...
Healio6d
FDA approves Evrysdi tablets for spinal muscular atrophy
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...